Elliott Michael James 4
4 · Immunovant, Inc. · Filed Sep 4, 2020
Insider Transaction Report
Form 4
Immunovant, Inc.IMVT
Elliott Michael James
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2020-09-04+400,000→ 400,000 totalExercise: $36.00Exp: 2030-09-04→ Common Stock (400,000 underlying)
Footnotes (1)
- [F1]25% of the shares underlying the option vest on August 24, 2021, and the remainder vest in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.